When LGG was administered to obese children with NAFLD for 8 weeks, BMI decreased and alanine transaminase (ALT), TNF-α, and antipeptidoglycan-polysaccharide antibodies were significantly reduced [91]. This evidence concerns the gene GPT and metabolic dysfunction-associated steatotic liver disease.